炎症性腸疾患と原発性免疫不全症

DOI HANDLE Web Site オープンアクセス
  • 白石 暁
    九州大学大学院医学研究院成長発達医学分野
  • 石村 匡崇
    九州大学大学院医学研究院成長発達医学分野
  • 江口 克秀
    九州大学大学院医学研究院成長発達医学分野
  • 園田 素史
    九州大学大学院医学研究院成長発達医学分野
  • 高田 英俊
    九州大学大学院医学研究院周産期・小児医療学
  • 大賀 正一
    九州大学大学院医学研究院成長発達医学分野

書誌事項

タイトル別名
  • Inflammatory Bowel Diseases and Primary Immunodeficiency
  • エンショウセイ チョウ シッカン ト ゲンパツセイ メンエキ フゼンショウ

この論文をさがす

抄録

Inflammatory bowel diseases (IBD) such as Crohnʼs disease and ulcerative colitis are critical disease, characterized by abdominal pain, diarrhea, bleeding and malabsorption. Approximately 25％ of IBD patients are diagnosed before the age of 18 years, particularly during puberty. Recently, biological therapies have modified the treatment strategies and have been shown to be effective and safe not only in adults but also children. Although IBD are suggested to result from dysregulation of immune system and environmental factors, the accurate etiology of IBD remains unknown. The genetic background of IBD has been focused for several years. According to recent studies, the number of IBD association loci has increased to about 200. The majority of IBD associated genes are involved in immune system. Indeed, IBD is one of the most common complications of primary immunodeficiency （PID). Thus, when we see IBD patients, PID should not be missed because prognosis and medical management are different from idiopathic IBD patients.

収録刊行物

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ